Richmond partner Erin Whaley’s discussion at the recent HIMSS Privacy & Security Forum about data breaches and privacy and security regulation issues companies face – and tips on how to avoid them – was featured in a May 12 Healthcare IT News (6 privacy landmines and how to avoid stepping on them). The forum, which was held in Los Angeles, is a national event dedicated to privacy and security in the healthcare field. Healthcare Finance also ran the article (Cybersecurity insurance, business agreements among major healthcare privacy pitfalls) on May 13.
May 16, 2016 No Comments
The healthIT world descended on Las Vegas in March for HIMSS16, the world’s largest conference for all things healthcare digital. Over 42,000 attendees networked and shared ideas about everything from cyber-security to interoperability to health IT policy. Here are our key take-aways: [Read more →]
April 8, 2016 No Comments
San Francisco partner Mark Mao and Richmond associate Reade Jacob had their article – “Why 2016 Will Be a Big Year for Big Data” – published January 13 in Law360. “The coming year will raise many questions about how e-commerce, social media and ‘ad tech’ may continue collecting and using consumer data. Last year, legal developments left organizations that store and collect consumer information to wonder: (1) What are the limitations of data collection on the Internet; (2) how can data be used; and (3) what are ‘best practices’ going forward?” the duo lay out in the opening of their article. [Read more →]
January 14, 2016 No Comments
2015 Revisions to the Federal Rules of Civil Procedure Effective Today: 5 Key Practice Pointers to Meeting the New Requirements
Today is the big day! New amendments to the Federal Rules of Civil Procedure (“Rules”) become effective. Are you ready? Details about the revised Rules, including the text of the Rules, redlines, and detailed comments are available here (and we will post additional information on each key provision in the coming weeks). The focus of this post is answering one simple question: how will these changes impact the way you handle discovery? To comply with the spirit and the letter of these rule changes, you may need to make some adjustments to your discovery practice.
The revised Rules emphasize case management and proactive discovery by adding several mechanisms to front-load discovery decisions and emphasize proportionality in the discovery process. They also provide guidance for when sanctions for failure to preserve electronically stored information (“ESI”) are appropriate. How courts will apply these Rules is subject to debate, but if you adhere to the five practice pointers below, you should be in good shape to avoid sanctions, reduce risks, and get to the merits of your case without a discovery sideshow.
[Read more →]
December 1, 2015 No Comments
CFPB Imposes $13 Million FCRA Consent Order on Large Consumer Reporting Agencies Due to Employment Background
On October 29, 2015, the Consumer Financial Protection Bureau (“CFPB”) announced the settlement of an enforcement action against two affiliated consumer reporting agencies under the Fair Credit Reporting Act (“FCRA”) based on these companies’ employment background screening practices. The consent order requires these background screeners to pay a total of $13 million in penalties and consumer redress. The Order also requires significant changes in the companies’ practices with regard to matching and use of public record information. This enforcement action provides another example of the CFPB flexing its regulatory muscle in the FCRA arena. All consumer reporting agencies (“CRAs”), all businesses that furnish data to a CRA (“furnishers”), and all users of data obtained from a CRA (“users”) should be concerned about the CFPB’s use of its enforcement authority. [Read more →]
November 6, 2015 No Comments
A new putative class action lawsuit has been filed against the hotel chain owned by Donald Trump in the United States District Court for the Southern District of Illinois, after the hotel chain revealed that it had been the subject of a data breach. The suit asserts claims under “state consumer protection laws” and “state data breach notification statutes” of the states of the affected class members, along with claims of negligence, breach of implied contract, and unjust enrichment. [Read more →]
October 21, 2015 No Comments
When the FTC revised its Endorsement Guides in 2009, it signaled that it would focus more of its efforts on deceptive advertising conveyed through social media and evolving methods of online advertising. The FTC warned advertisers that they risk enforcement action when material connections between an endorser and an advertiser are not disclosed, regardless of where the endorsement appears.
Since then, the FTC has kept that promise, and last week announced that it settled a case against Machinima involving its deployment of “influencers” who were paid to “build an early buzz” surrounding the launch of Microsoft’s Xbox One console in late 2013.
September 9, 2015 No Comments
The Federal Trade Commission scored a major win today in its efforts to regulate cybersecurity when the Third Circuit affirmed that the agency can exercise its unfair practices jurisdiction to sue companies that do not take reasonable data security measures.
The FTC sued Wyndham Worldwide Corp. in district court after hackers obtained over 600,000 consumers’ credit card information from the hotel group’s systems in 2008 and 2009, resulting in over $10 million in fraudulent charges. Unlike virtually all other FTC cybersecurity cases, Wyndham opted to challenge the FTC’s authority rather than settling.
August 25, 2015 No Comments
U.S. Senator Chuck Schumer (D. N.Y.) has introduced a bill that would criminalize the act of knowingly initiating a commercial robocall without the prior express written consent of the recipient.
The bill, S. 1681, defines a “commercial robocall” as a telephone call made for the purpose soliciting a purchase, rental, enrollment or investment in goods or services using an “automatic telephone dialing system” or an artificial or prerecorded voice.
August 14, 2015 No Comments
Tens of millions of people around the world follow Kim Kardashian’s every move on social media. So apparently does the FDA’s Office of Prescription Drug Promotion. Last week, the FDA issued a Warning Letter to Canadian drug manufacturer Duchesnay concerning Kardashian’s social media posts promoting the morning sickness drug Diclegis. The FDA warned that the posts unlawfully misbranded Diclegis under the Federal Food, Drug, and Cosmetic Act. [Read more →]
August 13, 2015 No Comments